Lilly's Zepbound enhances Taltz efficacy in psoriasis study
A study has shown that the efficacy of Lilly's psoriasis therapy Taltz is improved when it is given in combination with weight-loss drug Zepbound.
Newsletters and Deep Dive digital magazine
A study has shown that the efficacy of Lilly's psoriasis therapy Taltz is improved when it is given in combination with weight-loss drug Zepbound.
For many Hispanic patients and families, that is where the gap between need and treatment can begin.
This year’s World Sight Day turns global attention to the scale of preventable vision loss
The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks